We are live on ! Find out more
DL

Daniel Loeb Third Point

AUM $4.68B
1-Year Est. Return 37.3%
 

Daniel Loeb is the founder of Third Point, an event-driven and activist-oriented hedge fund. He is known for pointed letters to management teams, catalyst-driven investing, and a flexible mandate across equities and credit. Loeb’s campaigns and portfolio shifts regularly generate attention beyond specialist hedge fund circles.

This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+37.3%
3 Year Est. Return
+159.48%
5 Year Est. Return
+329.12%
10 Year Est. Return
+1,791.94%
AUM
$7.44B
AUM Growth
+$11.5M
Cap. Flow
-$468M
Cap. Flow %
-6.29%
Top 10 Hldgs %
56.96%
Holding
52
New
10
Increased
11
Reduced
9
Closed
9

Top Sells

Rank Stock Value
1
BBWI icon
Bath & Body Works
BBWI
+$376M
2
VST icon
Vistra
VST
+$302M
3
AAPL icon
Apple
AAPL
+$217M
4
ROP icon
Roper Technologies
ROP
+$134M
5
MSFT icon
Microsoft
MSFT
+$115M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.23%
2 Financials 15.49%
3 Technology 15.32%
4 Utilities 15%
5 Communication Services 12.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JWSM.WS
51
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
-1,000,000
Closed -$23.1K

Similar funds

Daniel Loeb's Q4 2024 Portfolio in Review

As of Q4 2024, Daniel Loeb held 52 positions worth $7.44B, up 0.15% from $7.43B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Daniel Loeb withdrew a net $468M in Q4 2024, closing 9 positions and reducing 9 holdings. Its most notable exit was Bath & Body Works, an estimated $376M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, Daniel Loeb opened a new position in Thermo Fisher Scientific worth $182M.

  • Daniel Loeb's largest Q4 2024 buy was Thermo Fisher Scientific: 350,000 shares worth $182M.
  • Daniel Loeb added most to Telephone and Data Systems in Q4 2024, an estimated $95.1M increase.
  • Daniel Loeb's biggest Q4 2024 reduction was Vistra, cutting an estimated $302M.
  • Daniel Loeb fully exited Bath & Body Works in Q4 2024, selling an estimated $376M.
  • Daniel Loeb's ten largest holdings make up 57% of its $7.44B portfolio in Q4 2024.
  • Daniel Loeb opened 10 new positions and closed 9 in Q4 2024.
  • Daniel Loeb's portfolio value rose 0.15% quarter-over-quarter to $7.44B.

Based on Third Point's 13F filing for Q4 2024, filed 14 Feb 2025.